BioAge Labs (BIOA) Non-cash Items (2023 - 2026)

BioAge Labs has disclosed Non-cash Items across 4 years of filings, most recently posting $75.3 million for Q1 2026.

• Non-cash Items for Q1 2026 came in at $75.3 million, up 48497.42% year-over-year; the trailing twelve-month figure through Mar 2026 was $75.3 million (up 48497.42% YoY), and the FY2025 annual result was $46.2 million, up 4425.05% from the prior year.
• Non-cash Items came in at $75.3 million for Q1 2026 at BioAge Labs, up from $46.2 million in the prior quarter.
• In the past five years, Non-cash Items ranged from a high of $75.3 million in Q1 2026 to a low of $155000.0 in Q1 2025.
• The 4-year median for Non-cash Items is $4.2 million (2023), against an average of $23.9 million.
• Across the five-year window, Non-cash Items plunged 90.78% in 2025 and soared 48497.42% in 2026, its largest moves.
• BioAge Labs' Non-cash Items stood at $2.9 million in 2023, then tumbled by 64.32% to $1.0 million in 2024, then jumped by 4425.05% to $46.2 million in 2025, then surged by 62.88% to $75.3 million in 2026.
• The last three Non-cash Items figures came in at $75.3 million (Q1 2026), $46.2 million (Q4 2025), and $5.5 million (Q3 2025), per Business Quant data.